MK-2206 Alleviates Renal Fibrosis by Suppressing the Akt/mTOR Signaling Pathway In Vivo and In Vitro

Renal fibrosis is a common pathological feature of various kidney diseases, leading to irreversible renal failure and end-stage renal disease. However, there are still no effective treatments to reverse renal fibrosis. This study aimed to explore the potential mechanism of a targeted drug for fibros...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Meiling, Yu, Yihang, Mi, Tao, Guo, Qitong, Xiang, Bin, Tian, Xiaomao, Jin, Liming, Long, Chunlan, Shen, Lianju, Liu, Xing, Pan, Jianbo, Zhang, Yuanyuan, Xu, Tao, Zhang, Deying, Wei, Guanghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655032/
https://www.ncbi.nlm.nih.gov/pubmed/36359901
http://dx.doi.org/10.3390/cells11213505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655032/
https://www.ncbi.nlm.nih.gov/pubmed/36359901
http://dx.doi.org/10.3390/cells11213505

Ejemplares similares